Skip survey header

ISTH Gene Therapy

ISTH Gene Therapy for Hemophilia

Thank you for taking this survey about gene therapy as a treatment option for hemophilia. The survey is being conducted by the International Society on Thrombosis and Haemostasis. The survey will take approximately 5 minutes to complete. Your participation is voluntary and all responses will be confidential. The results of this survey will help the development of educational programs and content for physicians and other healthcare professionals involved in the care of patients with hemophilia, as well as scientists with an interest in basic, translational, and clinical research in hemophilia and gene therapy.
 
1. Which of the following best describes your professional category? Select one
  *This question is required.
2. What is your area of primary clinical/laboratory focus? Select one *This question is required.
3. What is your role in the care of individuals with hemophilia? Select all that apply *This question is required.
4. What percentage of your professional time is devoted to hemophilia patient care and/or basic/clinical research related to hemophilia? Select one *This question is required.
5. How many years of experience do you have in your current profession? Select one *This question is required.
6. Which of the following best describes your practice setting? Select one *This question is required.
7. Do you work in a Hemophilia Treatment Center or Hemostasis Center within the academic medical center?
8. How many adult patients (18 years or older) with hemophilia do you see each week? Select one *This question is required.
9. How many pediatric patients (less than 18 years old) with hemophilia do you see each week? Select one *This question is required.